Table 4 The prevalence of specific lesions in the dominant and non-dominant limb
Dominant limb (n = 47) | Non-dominant limb (n = 47) | p | |
|---|---|---|---|
Chondral lesions | |||
Grade 1 Pat, n (%) | 10 (21) | 12 (26) | 0.63 |
Grade 2 Pat, n (%) | 20 (43) | 21 (45) | 0.84 |
Grade 3 Pat, n (%) | 5 (11) | 4 (9) | 0.73 |
Grade 1 MCF, n (%) | 2 (4) | 7 (15) | 0.08 |
Grade 2 MCF, n (%) | 17 (36) | 17 (36) | >0.99 |
Grade 3 MCF, n (%) | 19 (40) | 15 (32) | 0.39 |
Grade 4 MCF, n (%) | 3 (6) | 0 (0) | 0.08 |
Grade 1 LCF, n (%) | 7 (15) | 7 (15) | > 0.99 |
Grade 2 LCF, n (%) | 23 (49) | 17 (36) | 0.21 |
Grade 3 LCF, n (%) | 3 (7) | 15 (32) | 0.002 |
Grade 4 LCF, n (%) | 1 (2) | 2 (4) | 0.56 |
Grade 1 MCT, n (%) | 8 (17) | 5 (11) | 0.37 |
Grade 2 MCT, n (%) | 26 (55) | 28 (60) | 0.68 |
Grade 3 MCT, n (%) | 5 (11) | 5 (11) | > 0.99 |
Grade 4 MCT, n (%) | 1 (2) | 0 (0) | > 0.99 |
Grade 1 LCT, n (%) | 7 (15) | 13 (28) | 0.13 |
Grade 2 LCT, n (%) | 23 (49) | 22 (47) | 0.84 |
Grade 3 LCT, n (%) | 1 (2) | 2 (4) | 0.56 |
Grade 4 LCT, n (%) | 2 (4) | 0 (0) | 0.15 |
Meniscal lesions | |||
Grade 1 AHLM, n (%) | 6 (13) | 5 (11) | 0.75 |
Grade 2 AHLM, n (%) | 20 (43) | 17 (36) | 0.53 |
Grade 3 AHLM, n (%) | 2 (4) | 1 (2) | 0.56 |
Grade 1 PHLM, n (%) | 6 (13) | 5 (11) | 0.75 |
Grade 2 PHLM, n (%) | 22 (47) | 24 (51) | 0.68 |
Grade 3 PHLM, n (%) | 1 (2) | 0 (0) | > 0.99 |
Grade 1 AHMM, n (%) | 6 (13) | 9 (19) | 0.4 |
Grade 2 AHMM, n (%) | 20 (43) | 21 (45) | 0.84 |
Grade 3 AHMM, n (%) | 1 (2) | 0 (0) | > 0.99 |
Grade 1 PHMM, n (%) | 6 (13) | 5 (11) | 0.75 |
Grade 2 PHMM, n (%) | 34 (72) | 35 (74) | 0.82 |
Grade 3 PHMM, n (%) | 3 (6) | 4 (9) | 0.69 |
Osteoarthritis, n (%) | 2 (4) | 2 (4) | > 0.99 |
Synovitis, n (%) | 5 (11) | 10 (22) | 0.16 |
Bone marrow edema, n (%) | 6 (13) | 4 (9) | 0.53 |
Subcortical bone lesion, n (%) | 8 (18) | 9 (20) | 0.97 |